-
In an increasingly small infectious-disease world characterized by speed, connectivity, and globalization, infection control professionals are emerging as the critical link between clinical care and public health, said Julie Gerberding, MD, director of the Centers for Disease Control and Prevention (CDC).
-
-
Iron sucrose injection (Venofer); Sodium ferric gluconate complex (Ferrlecit),referred to as iron gluconate, and Iron dextran (DexFerrum/Infed).
-
Guilford Pharmaceuticals has initiated a Phase III clinical development program for Aquavan injection, a novel sedative/hypnotic that is a proprietary water-soluble prodrug of propofol.
-
Decision tool available on tablet splitting; Severe sufferers prefer brand name meds; Study: Medicare drug plan is confusing to elderly; Applications available for safety award.
-
The system often is blamed when pharmacists fill prescriptions incorrectly. For example, pharmacists may say they were distracted by a busy workplace, resulting in the misfilling of the orders. A new report, however, says some pharmacists are predisposed to medical errors due to individual factors, such as a lack of working memory.
-
Despite calls for aggressive action by some epidemiologists, new draft federal guidelines on multidrug-resistant organisms (MDROs) argue against adoption of the most comprehensive methods as the sole approach to this problem.
-
Denise Murphy, RN, MPH, CIC, chief of patient safety at Barnes Jewish Hospital at Washington University Medical Center in St. Louis, and colleagues developed the following scenarios to assist infection control professionals in identifying sentinel events related to infections.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA).
-
The results of two recent Phase III clinical trials indicate that docetaxel (Taxotere) extends life in advanced prostate cancer patients who are resistant to hormone therapy, supporting the Food and Drug Administrations approval of docetaxel injection, in combination with prednisone, for the treatment of patients with advanced metastatic prostate cancer.
